Company Filing History:
1 out of 832,843 Years Active: 1984
Title: Innovations by Peter O Milch in Glucose Control
Introduction
Peter O Milch is an inventor based in Coram, NY (US), known for his significant contributions to the field of medical technology. He holds a patent for an innovative electromagnetic apparatus designed to control glucose levels in living animals afflicted with hyperglycemia. His work aims to provide a non-invasive method for managing this condition, which is crucial for the health of many individuals.
Latest Patents
Peter O Milch's notable patent is titled "Electromagnetic apparatus and method for the reduction of serum glucose." This invention discloses an apparatus and technique that applies a uniform, monopolar pulsed magnetic field to generate electric currents in animals. The method is particularly focused on controlling glucose levels in animals suffering from hyperglycemia. The apparatus utilizes Helmholtz coils to transmit individual pulses of direct current, creating a pulsed magnetic field that has shown promising results in reducing serum glucose levels in test subjects.
Career Highlights
Throughout his career, Peter O Milch has demonstrated a commitment to advancing medical technology. His innovative approach to glucose control reflects his dedication to improving the quality of life for those affected by diabetes and related conditions. The results from his experiments with a breed of white rats indicate that while normal serum glucose levels were not achieved, the treated animals exhibited significantly lower glucose levels compared to control groups.
Collaborations
Peter O Milch has worked alongside Eugene Findl, contributing to the development and refinement of his patented technology. Their collaboration has been instrumental in advancing the research and application of electromagnetic methods in medical treatments.
Conclusion
Peter O Milch's work in developing an electromagnetic apparatus for glucose control represents a significant advancement in non-invasive medical technology. His innovative approach has the potential to impact the management of hyperglycemia in living animals, paving the way for future research and applications in human medicine.